Latest / The 7investing Podcast
The Third Biologic Revolution with Vaxxinity CEO Mei Mei Hu
There's big money to be make in drug development. But is that necessarily a good thing?
Pharmaceutical companies capitalize on years of R&D work with exclusive patents. Approved drugs typically commercialize in developed markets that can support higher pricing through mature insurance reimbursement networks.
Yet serious diseases don't only occur in the developed world. Billions of people in developing economics need treatments as well. And they're often not able to afford the hundreds of thousands of dollars it costs for innovative approaches such as CRISPR gene editing or CAR-T gene therapy…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.